BioPorto Diagnostics will be exhibiting at ISNCON - the upcoming conference of the Indian Society of Nephrology this year held in the city of Ahmedabad. The exhibition will be a joint venture with CPC Diagnostics, one of BioPorto's two distributors in India.
Focus will be on promotion of The NGAL Test™ - BioPorto's kidney injury test for central lab application. BioPorto has high expectations to the Indian market in which The NGAL Test™ was licensed for sale around one year ago.
Business Development Manager Ishan Gupta (email@example.com) will represent BioPorto at the conference.
To learn more about ISNCON 2012 please visit: www.isncon2012.com